Quantcast

2013 Report on the International Epigenetics Drugs and Diagnostic Technologies Market – Trends And Forecasts to 2018

January 27, 2014

DUBLIN, January 27, 2014 /PRNewswire/ –

Research and Markets (
http://www.researchandmarkets.com/research/g3pk2m/epigenetics_drugs) has announced the
addition of the “2013 Report on the International Epigenetics Drugs and Diagnostic
Technologies Market – Trends And Forecasts to 2018″
[http://www.researchandmarkets.com/research/g3pk2m/epigenetics_drugs ] report to their
offering.

(Logo:
http://photos.prnewswire.com/prnh/20130307/600769 )

“2013 Report on the International Epigenetics Drugs and Diagnostic Technologies Market
- Trends And Forecasts to 2018″, on the epigenetics drugs and diagnostic technologies
market provides detailed analysis of the global market and helps in understanding the
driving forces for the growth of these technologies. The report also provides analysis of
the drugs market by the mechanism of its action namely, DNMT inhibitors and HDAC
inhibitors.

The report also discusses the diagnostic technologies market by types which include
DNA methylation and ChIP (Chromatin Immunoprecipitation) technology. Market size estimates
and forecasts for the period 2010 to 2018 has been given for each segment and sub-segment,
in terms of USD million, using 2010 as the base year. The market has also been segmented
geographically into four regions namely North America, Europe, Asia-Pacific, and Rest of
the World (RoW). Market size and forecast has been provided for each of these regions. A
detailed qualitative analysis of the factors responsible for driving and restraining the
growth of the epigenetics market and future opportunities are provided in the report.

Competitive landscape and end user analysis for the product types is highlighted and
the market players are profiled with attributes such as company overview, financial
overview, business strategies, product portfolio and recent developments.

The global epigenetics drugs and diagnostic technologies market is segmented into the
following categories:

        - Epigenetics Drugs Market, by Mechanism of Action
        - DNMT Inhibitors
        - Azacitidine (Vidaza)
        - Decitabine (Dacogen
        - HDAC Inhibitors
        - Vorinostat (Zolinza
        - Romidepsin (Istodax)
        - Epigenetics Diagnostic Technologies Market, by Types
        - DNA Methylation
        - Chromatin Immunoprecipitation (ChIP) Technology

Key Topics Covered:

        1 Preface

        2 Executive Summary

        3 Market Overview

        4 Epigenetics Drugs Market, By Mechanism Of Action

        5 Epigenetics Diagnostic Technology Market, By Types

        6 Global Epigenetics Technologies Market, By Geography

        7 Competitive Landscape

        8 Recommendations

        9 Company Profiles

Companies Mentioned:

        - 4SC
        - Acetylon Pharmaceuticals
        - Astex Pharmaceuticals
        - Celgene Corporation
        - Cellcentric
        - Celleron Therapeutics
        - Chroma Therapeutics
        - Eisai
        - Envivo Pharmaceuticals
        - Epigentek Group
        - Epizyme
        - Illumina
        - Mdxhealth
        - Merck & Company
        - Novartis International
        - Oncolys Biopharma
        - Pharmacyclics
        - Repligen Corporation
        - Spectrum Pharmaceuticals
        - Syndax Pharmaceuticals
        - Topotarge
        - Valirx

For more information visit

http://www.researchandmarkets.com/research/g3pk2m/epigenetics_drugs

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


    Photo: 

http://photos.prnewswire.com/prnh/20130307/600769

SOURCE Research and Markets


Source: PR Newswire



comments powered by Disqus